These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23251626)

  • 41. Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice.
    Rademeyer KM; R Nass S; Jones AM; Ohene-Nyako M; Hauser KF; McRae M
    J Neurovirol; 2024 Feb; 30(1):1-21. PubMed ID: 38280928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TAT peptide at treatment-level concentrations crossed brain endothelial cell monolayer independent of receptor-mediated endocytosis or peptide-inflicted barrier disruption.
    Wu MC; Wang EY; Lai TW
    PLoS One; 2023; 18(10):e0292681. PubMed ID: 37819924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS.
    Eugenin EA; Gamss R; Buckner C; Buono D; Klein RS; Schoenbaum EE; Calderon TM; Berman JW
    J Leukoc Biol; 2006 Mar; 79(3):444-52. PubMed ID: 16507710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple Faceted Roles of Cocaine in Potentiation of HAND.
    Cai Y; Yang L; Callen S; Buch S
    Curr HIV Res; 2016; 14(5):412-416. PubMed ID: 27009095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of CNS Viral Seeding by HIV
    Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.
    Buckner CM; Luers AJ; Calderon TM; Eugenin EA; Berman JW
    J Neuroimmune Pharmacol; 2006 Jun; 1(2):160-81. PubMed ID: 18040782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simvastatin protects against amyloid beta and HIV-1 Tat-induced promoter activities of inflammatory genes in brain endothelial cells.
    András IE; Rha G; Huang W; Eum S; Couraud PO; Romero IA; Hennig B; Toborek M
    Mol Pharmacol; 2008 May; 73(5):1424-33. PubMed ID: 18276775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.
    Ben Haij N; Planès R; Leghmari K; Serrero M; Delobel P; Izopet J; BenMohamed L; Bahraoui E
    PLoS One; 2015; 10(6):e0129425. PubMed ID: 26090662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity.
    Capone C; Cervelli M; Angelucci E; Colasanti M; Macone A; Mariottini P; Persichini T
    Free Radic Biol Med; 2013 Oct; 63():99-107. PubMed ID: 23665428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD44-mediated monocyte transmigration across Cryptococcus neoformans-infected brain microvascular endothelial cells is enhanced by HIV-1 gp41-I90 ectodomain.
    He X; Shi X; Puthiyakunnon S; Zhang L; Zeng Q; Li Y; Boddu S; Qiu J; Lai Z; Ma C; Xie Y; Long M; Du L; Huang SH; Cao H
    J Biomed Sci; 2016 Feb; 23():28. PubMed ID: 26897523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients.
    Danese S; Katz JA; Saibeni S; Papa A; Gasbarrini A; Vecchi M; Fiocchi C
    Gut; 2003 Oct; 52(10):1435-41. PubMed ID: 12970136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
    Choudhury A; Chung I; Panja N; Patel J; Lip GYH
    Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide.
    Wang H; Sun J; Goldstein H
    J Virol; 2008 Aug; 82(15):7591-600. PubMed ID: 18508884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.
    Lee SP; Ataga KI; Orringer EP; Phillips DR; Parise LV
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1626-31. PubMed ID: 16601237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
    Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
    Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication.
    Cafaro A; Barillari G; Moretti S; Palladino C; Tripiciano A; Falchi M; Picconi O; Pavone Cossut MR; Campagna M; Arancio A; Sgadari C; Andreini C; Banci L; Monini P; Ensoli B
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology.
    Thompson LJ; Genovese J; Hong Z; Singh MV; Singh VB
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine Increases CD14
    Calderon TM; Williams DW; Lopez L; Eugenin EA; Cheney L; Gaskill PJ; Veenstra M; Anastos K; Morgello S; Berman JW
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):353-370. PubMed ID: 28133717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments.
    Williams ME; Zulu SS; Stein DJ; Joska JA; Naudé PJW
    Neurobiol Dis; 2020 Mar; 136():104701. PubMed ID: 31837421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smoothened Agonist Reduces Human Immunodeficiency Virus Type-1-Induced Blood-Brain Barrier Breakdown in Humanized Mice.
    Singh VB; Singh MV; Gorantla S; Poluektova LY; Maggirwar SB
    Sci Rep; 2016 May; 6():26876. PubMed ID: 27241024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.